• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Next Steps for Recovery and Rehab

    Scratching the Surface: A Roundtable on Coatings and Treatments

    Influencers on the Orthopedic Implant Manufacturing Market
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    ODT's Most-Read Stories This Week—Aug. 13

    Dental 3D Printing Market is Expanding 20% Annually

    Study Results Released for Abbott's Concussion Blood Test

    Bone Growth Stimulators Market to Top $3B by 2030

    Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    ODT's Most-Read Stories This Week—Aug. 13

    The ODT 2022 Top 10 Orthopedic Device Companies

    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Genetic Risk for Joint Replacement Failure
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Orthopedic Device Evolution is Driven by Precision Technology

    mdHACM Allografts Demonstrate Potential in Treating Knee Osteoarthritis

    Radically Improving Medicine & Surgery with Light Field Technology

    A Call to Action in Orthopedics: We Need to Personalize Every Single Hip and Knee Surgery

    Giving Knee Replacement Surgery a Much-Needed Update
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Tiodize

    Braxton Manufacturing

    Modern Plastics

    Life Science Outsourcing Inc.

    AV&R
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    The Impact of U.S. Regulation on Medical Device Innovation

    ...

    The Impact of U.S. Regulation on Medical Device Innovation
    Related CONTENT
    • Bone Cancer: The Global Burden and Medtech Opportunity
    • Powering the Wearable Orthopedic Devices of the Future
    • Clinical Data Show Leg, Back Pain Improvement With Luna XD Implant
    • AAOS News: Orthobond to Unveil Antimicrobial Surface Tech
    • Able Medical Launches the Valkyrie Thoracic Fixation System
    Patricia Kontoudis, Associate, Regulatory Affairs, Musculoskeletal Clinical Regulatory Advisers LLC02.12.18
    Passion, inspiration, perseverance, altruism, and need have historically been the factors driving innovators. During World War II, antibiotics were scarce and chronic osteomyelitis and bone deficiencies such as non-unions and deformities were common. G.A. Ilizarov, a general surgeon in the Ural Mountains in Siberia at the time, saw a majority of his patients suffering from musculoskeletal injuries. He used modular ring external fixators with tensioned transosseous wires to stabilize bone fragments, introducing the concept of “local bone regeneration” using minimally invasive surgery. His method salvaged limbs, allowing disabled soldiers to avoid painful amputations and return to normal activity. While Ilizarov’s innovation was a result of necessity, it also stemmed from a passion to improve treatment for his patients. Today, large-scale innovation is scarce, not due to the lack of ideas, but rather to the difficulty of executing and implementing those notions. The biggest hurdle in getting a medical device to market is a lack of understanding of governmental regulatory processes. This has become an important part of a product’s lifecycle when transitioning from concept to implementation, particularly in the field of orthopedic products. This column discusses the current U.S. regulatory system for medical devices and its effects on innovation in the implantable orthopedic device industry.

    Medical Device Regulatory Pathways
    The pathway to market for new medical devices depends on the level of risk associated with that device. Higher risk devices, as defined by the U.S. Food and Drug Administration (FDA), must meet particularly stringent information criteria to be marketed in the United States (Table 1).


    Table 1: Comparison of the De Novo, 510(k), and PMA pathways in 2018

    A 510(k) is the most common regulatory pathway utilized by manufacturers, is appropriate for low- or moderate-risk devices, and is not often correlated with innovation. These devices attain marketing clearance by determining substantial equivalence to a predicate, specifically a product currently on the market. Substantial equivalence is defined as similarity of the devices with respect to intended use, design, energy used or delivered, materials, chemical composition, manufacturing process, performance, safety, effectiveness, labeling, biocompatibility, standards, and other characteristics, as applicable.

    In many cases, the most innovative devices are deemed high-risk due the absence of comparable products and follow either the de novo or PMA pathway. Truly high-risk devices, in which insufficient information exists to determine whether general and special controls are sufficient to provide reasonable assurance of the product’s safety and effectiveness, follow the PMA pathway. Novel devices that do not have a predicate are classified in the highest risk class, regardless of the level of actual risk it poses or the ability of general and special controls to assure safety and effectiveness. The de novo process allows these novel devices with low to moderate risk to be reclassified from a high-risk class, which requires a PMA, to a low or moderate risk class, which only entails a 510(k).

    Medical Device Innovation and the FDA
    Despite boasting the world’s largest medtech market and laying claim to some of the industry’s largest corporations the development of innovative devices is lagging in the United States.2 Medtech innovation is a broad term that can encompass any individual part of the product lifecycle such as design, function, or manufacturing. Product innovation can refer to the invention of new devices or the improvement of existing ones and can be either radical or incremental. Radical innovation is characterized by dramatic change while incremental innovation is defined by small changes that may or may not eventually lead to radical ingenuity. Innovation can also include adoption—taking an existing device and applying it in a way it was not previously intended, which often occurs in cross-industry innovation. According to an analysis of FDA databases from 2015 to 2017, 97.9 percent of submissions were 510(k)s while only 0.8 percent and 1.4 percent were de novos and PMAs, respectively. In the orthopedic industry specifically, 99.4 percent were 510(k)s and 0.6 percent were PMAs (Figure 1).


    Figure 1: Medical Device Submissions (2015-2017)

    While the U.S. orthopedic device sector remains strong (estimated to surpass $25 billion in value by 2024), these numbers show a disparity of innovative products coming to market.1,3 Aligning with the trend towards preventing and curing disease, the orthopedic industry is likely to see growth from complex products such as instrumentation for minimally invasive surgery, combination devices, and customization in the near future.

    Impact of Regulation on Innovation
    The U.S. regulatory environment for medical devices generally inhibits the development of truly innovative products, as evidenced by the trend toward a greater number of submissions for incremental or low- to moderate-risk technologies. The current regulation for assessing the safety and efficacy of medical devices was developed in 1976; the scope and types of devices currently in development are quite different than those envisioned 40 years ago. Consequently, the industry is questioning whether the regulations are still ideal for ensuring product safety and effectiveness without adding undue burden to the manufacturer. According to MCRA’s review of FDA’s published guidance documents, there currently are 874 guidance documents specific to medical devices alone, compared with 318 in 1999. In addition, increasing non-clinical and clinical data requirements outlined in these guidance documents add cost and time in order to bring these devices to the market. This increasingly complex regulatory system leads to medical device companies having difficulty navigating the pathway towards bringing their latest inventions to customers.

    The result of this increased regulatory burden corresponds to a substantial increase in the cost of bringing a device to market. In 2014, this cost under the 510(k) pathway was about $31 million, compared to about $94 million under the PMA pathway.4 In order to promote innovation in the United States, steps must be taken to correct the shortcomings of the regulatory process and create a landscape where developing innovative technologies is in the best interest of the industry.

    Conclusions
    The current industry landscape for innovative medical devices has become more competitive and challenging, with significant regulatory hurdles blocking the path to the U.S. market. While the FDA’s first priority should always be to ensure public safety, the agency also has an important responsibility to provide the U.S. population with access to innovative and beneficial products. The Center for Devices and Radiological Health at the FDA recently released a 2018-2020 Strategic Priorities Document outlining its commitment to better public access to high-quality innovative technology, outlining a two-year goal to help at least 50 percent of medtech manufacturers debut their devices first in the United States or in parallel with other major markets (the deadline is Dec. 31, 2020).5 In light of this announcement, FDA reviewers should continue focusing on transparency and providing clear guidance to industry while also using their scientific expertise to exercise flexibility to relieve the burden of the regulatory process whenever possible. Simultaneously, medical device companies should consider the regulatory process from the beginning of the product’s lifecycle and communicate openly with the FDA to ensure efficiency. Nonetheless, healthcare is entering an exciting period and medical devices have the opportunity to make an enormous impact on prevention, treatment, and eradication of disease. Proper collaboration between companies and regulatory bodies will accelerate the rate at which innovative, game-changing technologies are available to the public. 

    References
    1. http://prn.to/2BETXHV
    2. http://bit.ly/2EqIIpH
    3. http://bit.ly/2DMfOiI
    4. http://bit.ly/2ntrYpI
    5. http://bit.ly/2nnBoUi

    Patricia Kontoudis is a regulatory associate at Musculoskeletal Clinical Regulatory Advisors (MCRA), primarily focusing on developing regulatory strategies and submissions to the U.S Food and Drug Administration, as well as drafting clinical evaluation reports and control documentation for clients worldwide. She is knowledgeable in regulatory pathways for medical devices, with a focus in combination and orthopedic devices. She possesses a broad spectrum of knowledge in the areas of FDA regulations, mechanical systems and the interface between technology and biology. She attended Drexel University and graduated with a Bachelor of Science degree in biomedical engineering with a concentration in tissue engineering and biomaterials.  
    Related Searches
    • medical device
    • surgeon
    • medical devices
    • antibiotics
    Suggested For You
    Bone Cancer: The Global Burden and Medtech Opportunity Bone Cancer: The Global Burden and Medtech Opportunity
    Powering the Wearable Orthopedic Devices of the Future Powering the Wearable Orthopedic Devices of the Future
    Clinical Data Show Leg, Back Pain Improvement With Luna XD Implant Clinical Data Show Leg, Back Pain Improvement With Luna XD Implant
    AAOS News: Orthobond to Unveil Antimicrobial Surface Tech AAOS News: Orthobond to Unveil Antimicrobial Surface Tech
    Able Medical Launches the Valkyrie Thoracic Fixation System Able Medical Launches the Valkyrie Thoracic Fixation System
    Alex Gorsky to Step Down as J&J CEO in 2022 Alex Gorsky to Step Down as J&J CEO in 2022
    Back in 3D: AMUG Conference Welcomes Members in the Flesh Back in 3D: AMUG Conference Welcomes Members in the Flesh
    Medical Device IP Strategy, Part I: Creating a Patent Strategy that Protects Your Revenue Model Medical Device IP Strategy, Part I: Creating a Patent Strategy that Protects Your Revenue Model
    WishBone Medical Recieves $10 Million in Growth Capital WishBone Medical Recieves $10 Million in Growth Capital
    FDA OKs Aurora Spine FDA OKs Aurora Spine's DEXA-C Cervical Interbodies
    Relievant Medsystems Names Tyler Binney President and CEO Relievant Medsystems Names Tyler Binney President and CEO
    Intech Partners with Montagu Intech Partners with Montagu
    Potential Concerns with NuVasive MAGEC System Implants Potential Concerns with NuVasive MAGEC System Implants
    Self-Powered Implant Stimulates Fast Bone Healing, Then Disappears Self-Powered Implant Stimulates Fast Bone Healing, Then Disappears
    Robotic-Assisted Knee Reconstructions to Grow 8 Percent Annually Robotic-Assisted Knee Reconstructions to Grow 8 Percent Annually

    Related Columns

    • Bone Cancer: The Global Burden and Medtech Opportunity

      Bone Cancer: The Global Burden and Medtech Opportunity

      There are so many medical devices critical to the treatment of cancer.
      Maria Shepherd, President and Founder, Medi-Vantage 09.14.21

    • Bracing/Prosthetics
      Powering the Wearable Orthopedic Devices of the Future

      Powering the Wearable Orthopedic Devices of the Future

      How wirelessly powered biosensors will completely change the direction of orthopedic medical device innovation.
      Hatem Zeine, Founder and President, Ossia 09.13.21

    • Spine/Neurology
      Clinical Data Show Leg, Back Pain Improvement With Luna XD Implant

      Clinical Data Show Leg, Back Pain Improvement With Luna XD Implant

      Product allows an ALIF-sized, circular implant to be surgically delivered to the intervertebral space through a posterior, minimally-invasive access point.
      Business Wire 08.27.21


    • Coatings/Surface Modification
      AAOS News: Orthobond to Unveil Antimicrobial Surface Tech

      AAOS News: Orthobond to Unveil Antimicrobial Surface Tech

      Eliminates microbes on metallic and polymeric surfaces.
      Business Wire 08.25.21

    • Able Medical Launches the Valkyrie Thoracic Fixation System

      Able Medical Launches the Valkyrie Thoracic Fixation System

      The product is a single-use, bioactive sternal plating system for use after open heart surgery.
      Business Wire 08.24.21

    Loading, Please Wait..

    Trending
    • MdHACM Allografts Demonstrate Potential In Treating Knee Osteoarthritis
    • Bioventus Launches DUROLANE In The U.S.
    • Custom 3D-Printed Titanium Lower Jaw Used In First Successful Surgery
    • ARCH Medical Solutions Acquires Titan Medical Manufacturing
    • Future Stars Of The Spine Industry: The Companies To Watch, 2021
    Breaking News
    • ODT's Most-Read Stories This Week—Aug. 13
    • Dental 3D Printing Market is Expanding 20% Annually
    • Study Results Released for Abbott's Concussion Blood Test
    • Bone Growth Stimulators Market to Top $3B by 2030
    • Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Additive Manufacturing at the Point of Care
    • Six Orthopedic Firms En Route to Significant Market Disruption
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Aug. 13
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Consumers are Clamoring for Vintage Glam: Spate
    Kayali’s Lovefest Fragrance, Newell’s New Candle and HydraFacial’s Record Financial Results
    Self Care Trumps Home Care Post-Covid
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Aug. 13
    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login